Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Homebound older adults face a high burden of depression and substantial barriers to accessing mental health treatments. Few interventions address their specific needs. Empower@Home, an internet-based cognitive behavioral therapy program, was co-designed with stakeholders and tailored to older adults. The program includes 9 self-paced online sessions to be completed within 12 weeks, augmented by telephone-based human support. Efficacy studies have demonstrated its acceptability and effectiveness in reducing depression when supported by trained research staff. However, its real-world effects and feasibility for integration into community aging service settings remain unknown.

Objective: This study aims to assess the real-world effectiveness of Empower@Home integrated into aging services, using nonclinician agency staff as coaches to support older adults. A secondary objective is to evaluate the implementation process through a qualitative process evaluation.

Methods: The study is a type 1 hybrid effectiveness-implementation trial with a 2-arm randomized controlled design. A total of 256 homebound older adults will be recruited from 3 community aging service agencies, and agency staff will be trained as coaches to support internet-based cognitive behavioral therapy use. Participants in the treatment group will receive Empower@Home immediately, while the control group will receive biweekly friendly calls and enhanced care as usual, including the provision of psychoeducational materials and usual care. Outcomes will be assessed at baseline, after the intervention (12 weeks), and at 2 follow-up points (24 and 36 weeks). The primary outcome is a change in depressive symptoms as measured by the 9-item Patient Health Questionnaire. Secondary outcomes include changes in social isolation, health-related quality of life, disability burden, pain intensity, and anxiety symptoms.

Results: Institutional review board approval was obtained in August 2024, and recruitment began in October 2024. Recruitment is expected to conclude by April 2028. Upon trial completion, the effectiveness of Empower@Home on primary and secondary outcomes will be analyzed.

Conclusions: This study will provide critical insights into the real-world effectiveness of Empower@Home. If successful, this study will provide a scalable, cost-effective model for integrating technology-assisted mental health treatments into community aging services, thereby improving access to care for an underserved, hard-to-reach population.

Trial Registration: ClinicalTrials.gov NCT06584422; https://clinicaltrials.gov/study/NCT06584422.

International Registered Report Identifier (irrid): DERR1-10.2196/72953.

Download full-text PDF

Source
http://dx.doi.org/10.2196/72953DOI Listing

Publication Analysis

Top Keywords

older adults
20
aging service
12
internet-based cognitive
12
cognitive behavioral
12
behavioral therapy
12
homebound older
12
community aging
12
effectiveness empower@home
12
support internet-based
8
type hybrid
8

Similar Publications

Importance: Increasingly, strategies to systematically detect melanomas invoke targeted approaches, whereby those at highest risk are prioritized for skin screening. Many tools exist to predict future melanoma risk, but most have limited accuracy and are potentially biased.

Objectives: To develop an improved melanoma risk prediction tool for invasive melanoma.

View Article and Find Full Text PDF

Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer.

JAMA Netw Open

September 2025

Oncostat U1018, Institut National de la Santé et de la Recherche Médicale (INSERM), Ligue Contre le Cancer, Paris-Saclay University, Villejuif, France.

Importance: Antibiotics, steroids, and proton pump inhibitors (PPIs) are suspected to decrease the efficacy of immunotherapy.

Objective: To explore the association of comedications with overall survival (OS) in patients with advanced non-small-cell lung cancer (NSCLC).

Design, Setting, And Participants: This nationwide retrospective cohort study used target trial emulations of patients newly diagnosed with NSCLC from January 2015 to December 2022, identified from the French national health care database.

View Article and Find Full Text PDF

Importance: The efficacy of home end-of-life care in enhancing the quality of life for terminally ill patients and families has been well documented. While previous studies have explored perspectives on quality home palliative care and end-of-life care in several countries, limited knowledge exists regarding its specific components in the Chinese context.

Objective: To explore the core elements that constitute quality home end-of-life care in China.

View Article and Find Full Text PDF

Importance: Research in behavioral economics has demonstrated that people have irrational biases, which make them susceptible to decisional shortcuts, or heuristics. The extent to which physicians consciously might use nudges to exploit these heuristics and thereby influence their patients' decision-making is unclear. In addition, ethical questions about the conscious use of nudges in medicine persist, yet little is known about how physicians experience and perceive their use.

View Article and Find Full Text PDF

Importance: Janus kinase (JAK) inhibitors are highly effective medications for several immune-mediated inflammatory diseases (IMIDs). However, safety concerns have led to regulatory restrictions.

Objective: To compare the risk of adverse events with JAK inhibitors vs tumor necrosis factor (TNF) antagonists in patients with IMIDs in head-to-head comparative effectiveness studies.

View Article and Find Full Text PDF